Skip to main content

Day: March 30, 2021

Kandi Technologies Reports Full Year 2020 Financial Results

– Full year revenue of $76.9 million– Electric Scooters, Electric Self-Balancing Scooters and associated parts sales was $5.8 m, up 160.5% yoy– Full year operating income of $0.8 million, stable with 2019– Year-end working capital surplus of $223 million  JINHUA, CHINA, March 30, 2021 (GLOBE NEWSWIRE) — Kandi Technologies Group, Inc. (the “Company,” “we” or “Kandi”) (NASDAQ GS: KNDI), today announced its financial results for the full year ended December 31, 2020. Full Year 2020 HighlightsTotal revenue was $76.9 million, compared to $135.7 million in 2019.EV parts sales were $40.6 million, compared to $110.7 million in 2019.Off-road vehicles sales increased by 31.1% to $29.8 million, compared to $22.7 million in 2019.EV product sales were $0.7 million, compared to $0.1 million in 2019.Electric...

Continue reading

908 Devices Reports Fourth Quarter and Full Year 2020 Financial Results and Provides 2021 Revenue Outlook

BOSTON, March 30, 2021 (GLOBE NEWSWIRE) — 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for the quarter and full year ended December 31, 2020. Financial Highlights2020 revenue increased 50% year over year to $26.9 million 2020 gross margin increased to 55% from 45% in prior year Completed initial public offering in December 2020, raising approximately $150 million in gross proceeds Expect full year 2021 revenue to be in the range of $38 million to $40 million, representing 45% growth over full year 2020, at the midpoint of the rangeBusiness HighlightsIncreased the installed base to 1,361 devices with 390 devices placed in 2020 Received a $25 million purchase order from the U.S. Army to be delivered...

Continue reading

Global Power Tools Market By Application, By Mode of Operation (By End User, By Region, Industry Analysis and Forecast, 2021 – 2028

Pune, India, March 30, 2021 (GLOBE NEWSWIRE) — The global power tools market is set to gain traction from the rising development of energy-efficient products equipped with state-of-the-art technologies. In January 2021, for instance, Milwaukee Tool unveiled the fastest cordless rivet tool named M18 FUEL™ ¼” Blind Rivet Tool w/ONE-KEY™. It delivers 3X longer life and is up to 50% faster compared to other power tools. This information is given by Fortune Business Insights™ in a new report, titled, “Power Tools Market, 2021-2028.” As per the report, the market size was USD 25.24 billion in 2020. It is projected to grow from USD 25.24 billion in 2020 to USD 33.05 billion in 2028 at a CAGR of 3.8% in the forecast period. To get to know more about the short-term and long-term impact of COVID-19 on this market, Please Visit: https://www.fortunebusinessinsights.com/industry-reports/power-tools-market-101444 A...

Continue reading

FactSet Reports Solid Results for Second Quarter 2021

NORWALK, Conn., March 30, 2021 (GLOBE NEWSWIRE) — FactSet (“FactSet” or the “Company”) (NYSE:FDS) (NASDAQ:FDS), a global provider of integrated financial information, analytical applications, and industry-leading service, today announced results for its second quarter ended February 28, 2021. Second Quarter Fiscal 2021 HighlightsRevenue increased 6.0%, or $22.0 million, to $391.8 million compared with $369.8 million for the same period in fiscal 2020. The increase is primarily due to higher sales of analytics and content and technology solutions (CTS). Organic revenues grew 4.9% to $389.2 million during the second quarter of fiscal 2021 from the prior year period. Annual Subscription Value (ASV) plus professional services was $1.6 billion at February 28, 2021, compared with $1.5 billion at February 29, 2020. The organic...

Continue reading

Cloud Analytics Market to Benefit from the Increasing Demand for Cloud Platforms in Numerous Software-based Applications

Pune, India, March 30, 2021 (GLOBE NEWSWIRE) — The global cloud analytics market size is projected to reach USD 72.40 billion by the end of 2026. The increasing use of cloud platforms in fraud detection software will have a positive impact on the growth of the market in the coming years. According to a report published by Fortune Business Insights, titled “Cloud Analytics Market Size, Share & Industry Analysis, By Deployment Type (Public Cloud, Private Cloud, and Hybrid Cloud), By Organization Size (Small And Medium-Sized Enterprises (SMEs) and Large Enterprises), By End-User (BFSI, IT and Telecommunications, Retail and Consumer Goods, Healthcare and Life Sciences, Manufacturing, Education, and Others) and Regional Forecast, 2019-2026,” the market was worth USD 13.15 billion in 2018 and will exhibit a CAGR of 24.3% during the...

Continue reading

Robotic Welding Market to Exhibit 7.6% CAGR Backed by Increasing Adoption of Automation Technology Globally, states Fortune Business Insights™

Pune, India, March 30, 2021 (GLOBE NEWSWIRE) — The global robotic welding market size is expected to gain momentum by reaching USD 8.31 billion by 2027 while exhibiting a CAGR of 7.6% between 2020 and 2027. This is attributable to the increasing adoption of automation in the manufacturing process that propels the demand for advanced robotic welding machines across the globe. This information is published by Fortune Business Insights, in its latest report, titled, “Robotic Welding Market Size, Share & COVID-19 Impact Analysis, By Type (Arc, Spot, MIG/TIG, Laser, Others (Plasma etc.)), By Payload Capacity (Low (6-22 kg), Medium (30-60 kg), High (80-300kg)) By Industry (Automotive, Aerospace & Defense, Construction, Mining, Railway & Shipbuilding, Electrical & Electronics, Others) and Regional Forecast, 2020-2027.”...

Continue reading

Wound Closure Market Size 2021 | To Exhibit 6.0% CAGR and Hit USD 21.03 Billion by 2026

Pune, India, March 30, 2021 (GLOBE NEWSWIRE) — The global wound closure market is set to gain impetus from the ever-increasing inclination of people from traditional suturing techniques to innovative devices, namely, hemostatic agents, clips, and staplers. It is mainly occurring in countries such as India, China, Japan, Germany, and the U.S. Fortune Business Insights™ provided this information in a recent report, titled, “Wound Closure Market Size, Share & Industry Analysis, By Product Type (Sutures, Hemostatic Agents, Staplers, Staples, and Others), By Application (Gynaecology, Cardiology, Orthopedics, Ophthalmic, General Surgery, and Others), By End User (Hospitals and Ambulatory Surgical Centers, Specialty Clinics, and Others), and Regional Forecast, 2019-2026.” The report further mentions that the wound closure market size...

Continue reading

QIWI Announces Unaudited Fourth Quarter and Full Year 2020 Financial Results

Fourth Quarter Total Net Revenue Decreases 0.2% to RUB 6,242 Million and Adjusted Net Profit Increases 116% to RUB 2,519 Million or RUB 40.32 per diluted shareFull-Year 2020 Total Net Revenue Increases 12% to RUB 25,978 Million and Adjusted Net Profit Increases 54% to RUB 10,304 Million or RUB 165.09 per diluted shareQIWI gives 2021 GuidanceBoard of Directors Approves Dividend Payout Ratio for 2021QIWI announces CEO succession NICOSIA, Cyprus, March 30, 2021 (GLOBE NEWSWIRE) — QIWI plc (NASDAQ: QIWI) (MOEX: QIWI) (“QIWI” or the “Company”) today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2020. Fourth Quarter 2020 Operating and Financial HighlightsTotal Net Revenue decreased 0.2% to RUB 6,242 million ($84.5 million) Payment Services Segment Net Revenue increased 6% to RUB 5,811...

Continue reading

BioNTech Announces Full Year 2020 Financial Results and Corporate Update

BNT162b2 vaccine approved or authorized for emergency or temporary use in over 65 countries and regions after successful global Phase 3 trial demonstrated safety and efficacy in preventing COVID-19. More than 200 million doses of BNT162b2 supplied as of March 23, 2021, with signed orders for 1.4 billion doses to date for delivery in 2021. BioNTech and Pfizer expect to expand manufacturing capacity to up to 2.5 billion doses by end of 2021. Evaluation of safety and immunogenicity of a third BNT162b2 dose initiated to understand the effect of a booster to prolong immunity and protection against COVID-19 caused by the circulating and potential newly emerging SARS-CoV-2 variants, with additional studies planned. In oncology, first patient dosed in first-in-human trials for CARVac (BNT211) and RiboCytokines (BNT151). Development of oncology...

Continue reading

BioNTech veröffentlicht Ergebnisse des Geschäftsjahres 2020 und Informationen zur Geschäftsentwicklung

BNT162b2-Impfstoff erhielt in mehr als 65 Ländern und Regionen Notfallzulassungen oder bedingte Zulassungen, nachdem die erfolgreiche globale Phase-3-Studie die Sicherheit und Wirksamkeit zum Schutz vor COVID-19 gezeigt hat. Mehr als 200 Millionen BNT162b2-Impfstoffdosen wurden bis zum 23. März 2021 ausgeliefert; im Rahmen von aktuellen Bestellungen werden 2021 insgesamt über 1,4 Milliarden Dosen ausgeliefert; BioNTech und Pfizer rechnen mit einer Erweiterung der Produktionskapazität auf bis zu 2,5 Milliarden Impfstoffdosen bis Ende 2021. Evaluierung von Sicherheit und Immunogenität einer dritten BNT162b2-Dosis als Auffrischungsimpfung begonnen, um die Verlängerung der Immunität und den Schutz vor einer COVID-19-Erkrankung zu untersuchen, die durch die zirkulierenden und möglicherweise neu auftretenden SARS-CoV-2-Varianten entstehen...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.